Advertisement

Pharmaceutical Chemistry Journal

, Volume 24, Issue 8, pp 538–549 | Cite as

Current state of drug therapy for atherosclerosis (review)

  • G. Ya. Shvarts
Search for New Drugs
  • 26 Downloads

Keywords

Atherosclerosis Organic Chemistry Drug Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    I. S. Varpakhovskaya, Byull. Inostrann. Kommerch. Inform., No. 38 (6395), 6–7 (1989).Google Scholar
  2. 2.
    A. N. Klimov, Lipids: Structure, Biosynthesis, Reactions, and Functions [in Russian], Moscow (1977), pp. 55–80.Google Scholar
  3. 3.
    A. N. Klimov and N. G. Nikul'cheva, Dyslipoproteinemia and Ischemic Cardiac Disease [in Russian], E. I. Chazov and A. N. Klimov (eds.), Moscow (1980), pp. 10–25.Google Scholar
  4. 4.
    R. G. Oganov, G. S. Zhukovskii, V. V. Konstantinov, et al., Kardiologiya,29, No. 5, 56–61 (1989).Google Scholar
  5. 5.
    V. E. Ryzhenkov, É. M. Tararak, G. G. Khechinashvili, and I. V. Mosina, Byull. Éksp. Biol.,81, No. 5, 558–559 (1976).Google Scholar
  6. 6.
    E. I. Chazov and A. N. Klimov, Dyslipoproteinemia and Ischemic Cardiac Disease [in Russian], E. I. Chazov and A. N. Klimov (eds.), Moscow (1980), pp. 3–8.Google Scholar
  7. 7.
    G. Ya. Shvarts, Khim.-farm. Zh., No. 11, 139–143 (1977).Google Scholar
  8. 8.
    L.-O. Aimer and T. Kjellstrom, Atherosclerosis,61, 81–85 (1986).Google Scholar
  9. 9.
    H. E. Andrews, K. R. Bruckdorfer, P. C. Dunn, and M. Jacobs, Nature,327, 237–239 (1987).Google Scholar
  10. 10.
    H. Arichi, Y. Kimura, H. Okuda, et al., Chem. Pharm. Bull.,30, 1766–1770 (1982).Google Scholar
  11. 11.
    R. F. Atmeh, J. Shepherd, and C. J. Packard, Biochim. Biophys. Acta,751, 175–188 (1983).Google Scholar
  12. 12.
    T. B. Barrett and E. P. Benditt, Proc. Natl. Acad. Sci. USA,84, 1099–1103 (1987).Google Scholar
  13. 13.
    J. L. Beaumont, J. Dyerberg, and A. Nelson, Bull. World Health Org.,43, 891–915 (1970).Google Scholar
  14. 14.
    C.-M. Becker and R. A. Harris, Arch. Biochem.,223, 381–392 (1983).Google Scholar
  15. 15.
    F. Bernini, R. Musanti, E. Trezzi, et al., Pharmacol. Res. Commun.,15, 201–215 (1983).Google Scholar
  16. 16.
    C. H. Bolton, T. K. Daneshmend, M. D. Eare, et al., Br. J. Clin. Pharmacol.,15, 152P-153P (1983).Google Scholar
  17. 17.
    A. L. Borresen, K. Berg, G. Dahlen, et al., Artery,9, 77–86 (1981).Google Scholar
  18. 18.
    M. Brownlee, H. Vlassara, A. Kooney, et al., Science,232, 1629–1632 (1986).Google Scholar
  19. 19.
    S. P. Bydlowski, Gen. Pharmacol.,17, 625–631 (1986).Google Scholar
  20. 20.
    L. A. Carlson and L. E. Bottiger, Lancet,1, 865 (1972).Google Scholar
  21. 21.
    M. N. Cayen, Prog. Drug Metab.,7, 173–227 (1983).Google Scholar
  22. 22.
    M. N. Cayen, M. A. Kallai-Sanfacon, J. Dubuc, et al., Atherosclerosis,45, 319–325 (1982).Google Scholar
  23. 23.
    C. Cortese, C. B. Marenach, N. E. Miller, and B. Lewis, Atherosclerosis,44, 319–325 (1982).Google Scholar
  24. 24.
    J. L. Day, J. Metcalfe, and C. N. Simpson, Br. Med. J.,283, 1145–1148 (1982).Google Scholar
  25. 25.
    EDRF, Lancet,II, No. 8551, 137–138 (1987).Google Scholar
  26. 26.
    H. D. Fahimi, A. Reinicke, M. Sujatta, et al., Ann. NY Acad. Sci.,386, 111–135 (1982).Google Scholar
  27. 27.
    R. Fears, Biochem. Soc. Trans.,11, 642–644 (1983).Google Scholar
  28. 28.
    R. Fears, 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase, J. Sabine (ed.), Boca Raton (1983), pp. 189–208.Google Scholar
  29. 29.
    R. Fears, Drugs Today,20, 257–294 (1984).Google Scholar
  30. 30.
    R. Fears, Drugs Today,23, 295–300 (1987).Google Scholar
  31. 31.
    R. Fears, Drugs Today,25, 33–64 (1989).Google Scholar
  32. 32.
    R. Fears, K. H. Baggaley, R. Alexander, et al., J. Lipid Res.,19, 3–11 (1978).Google Scholar
  33. 33.
    R. Fears, D. H. Richards, and H. Ferres, Atherosclerosis,35, 439–449 (1980).Google Scholar
  34. 34.
    R. Fears and D. H. Richards, Biochem. Soc. Trans.,9, 572–573 (1981).Google Scholar
  35. 35.
    R. Fears, W. K. Rush, P. Walker, and H. Ferres, Biochem. Pharmacol.,33, 209–217 (1984).Google Scholar
  36. 36.
    R. Fears, A. Esmail, P. Walker, et al., Biochem. Pharmacol.,33, 219–228 (1984).Google Scholar
  37. 37.
    H. Ferres, I. K. Hatton, L. J. A. Jennings, et al., Tetrahedron Lett.,24, 3769–3772 (1983).Google Scholar
  38. 38.
    D. S. Fredrickson, R. I. Levy, and R. S. Less, New Engl. J. Med.,276, 34–44 (1967).Google Scholar
  39. 39.
    G. B. Fregnan, L. Frigerio, and R. Porta, Pharmacology,22, 311–321 (1981).Google Scholar
  40. 40.
    Y. Fujita, K. Sempuki, K. Kitaguchi, et al., Chem. Pharm. Bull.,28, 453–458 (1980).Google Scholar
  41. 41.
    C. J. Glueck, Ann. Intern. Med.,96, 475–482 (1982).Google Scholar
  42. 42.
    J. L. Goldstein and M. S. Brown, Arch. Pathol.,99, 181–184 (1975).Google Scholar
  43. 43.
    M. E. Haberland and A. M. Fogelman, Am. Heart J.,113, 573–577 (1987).Google Scholar
  44. 44.
    H. Hayashi, K. Fukuyama, and F. Yamasaki, Chem. Pharm. Bull.,31, 653–658 (1983).Google Scholar
  45. 45.
    C. H. Heathcock, M. J. Taschner, T. Rosen, et al., Tetrahedron Lett.,23, 4747–4750 (1982).Google Scholar
  46. 46.
    W. E. Heyd, L. T. Bell, J. R. Heystek, et al., J. Med. Chem.,25, 1101–1103 (1982).Google Scholar
  47. 47.
    R. M. Hodges and E. L. Marcus, Res. Clin. Forum,4, 35–42 (1984).Google Scholar
  48. 48.
    W. F. Hoffmann, A. W. Alberts, P. S. Anderson, et al., J. Med. Chem.,29, 849–852 (1986).Google Scholar
  49. 49.
    P. L. Hooper, W. Woo, L. Visconti, and D. R. Pathak, New Engl. J. Med.,305, 1455–1457 (1981).Google Scholar
  50. 50.
    K. Hudson and A. J. Day, Atherosclerosis,45, 100–113 (1982).Google Scholar
  51. 51.
    D. R. Illingworth and S. Bacon, Am. J. Cardiol.,60, 336–346 (1987).Google Scholar
  52. 52.
    L. Jonasson, J. Holm, O. Skalli, et al., Atherosclerosis,6, 131–138 (1986).Google Scholar
  53. 53.
    M. Kaste, A. Muuronen, E. A. Nikkila, and P. J. Neuvonen, Acta Neurol. Scand.,66, Suppl. 91, 18–19 (1982).Google Scholar
  54. 54.
    A. C. Katocs and S. A. Schaffer, Artery,11, 192–206 (1982).Google Scholar
  55. 55.
    A. Keys, Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease, Cambridge (1980).Google Scholar
  56. 56.
    T. Komabayashi, S. Sakamoto, and M. Tsuboi, Jpn. J. Pharmacol.,31, 975–978 (1981).Google Scholar
  57. 57.
    P. T. Kovanen, D. W. Bilheimer, J. L. Goldstein, et al., Proc. Natl. Acad. Sci. USA,78, 1194–1198 (1981).Google Scholar
  58. 58.
    D. M. Karamsch, A. J. Aspen, and A. C. Swindel, Fed. Proc.,42, 808 (1983).Google Scholar
  59. 59.
    P. Leren, P. O. Foss, A. Helgeland, et al., Lancet,2, 4–6 (1980).Google Scholar
  60. 60.
    J. E. Lewis, Pract. Cardiol.,9, 99–118 (1983).Google Scholar
  61. 61.
    M. J. Martiu, S. B. Hulley, W. S. Browner, et al., Lancet,2, 933–936 (1986).Google Scholar
  62. 62.
    Y. Maruhama, A. Nagasaki, Y. Kanazawa, et al., Tohoku J. Exp. Med.,132, 453–462 (1980).Google Scholar
  63. 63.
    N. E. Miller and B. Lewis, Lancet,1, 529–530 (1983).Google Scholar
  64. 64.
    M. J. T. M. Mol, D. W. Erkelens, J. A. Gevers Leuven, et al., Atherosclerosis,69, 131–137 (1988).Google Scholar
  65. 65.
    J. P. Monk and P. A. Todd, Drugs,33, 539–576 (1987).Google Scholar
  66. 66.
    G. Nunes, Curr. Ther. Res.,31, 193–200 (1982).Google Scholar
  67. 67.
    H. Ohnishi, C. Ito, K. Suzuki, et al., Folia Pharmacol. Jpn.,76, 469–477 (1980).Google Scholar
  68. 68.
    C. J. Packard and J. Shepherd, J. Lipid Res.,23, 1081–1098 (1982).Google Scholar
  69. 69.
    M. R. Parwaresch, H. Haacke, and Ch. Mader, Atherosclerosis,31, 395–401 (1978).Google Scholar
  70. 70.
    L. Pickart, Atherosclerosis,46, 21–28 (1983).Google Scholar
  71. 71.
    V. P. O. Rasi and I. Torstila, Proc. R. Soc. Med.,69, Suppl. 2, 64–70 (1976).Google Scholar
  72. 72.
    A. L. Robertson and P. A. Khairallah, Exp. Mol. Pathol.,18, 241–260 (1973).Google Scholar
  73. 73.
    G. Rodney and R. E. Maxwell, Proc. Soc. Exp. Biol. (NY),69, Suppl. 2, 6–10 (1976).Google Scholar
  74. 74.
    R. Ross, New Engl. J. Med.,314, 488–500 (1986).Google Scholar
  75. 75.
    W. R. Rush and R. Fears, Biochem. Pharmacol.,31, 2423–2426 (1982).Google Scholar
  76. 76.
    P. Samuel, Am. J. Med.,74, 23–27 (1983).Google Scholar
  77. 77.
    P. Schulzeck, A. Jochim, M. Bojanovski, et al., Lancet,1, No. 8586, 611–612 (1988).Google Scholar
  78. 78.
    W. Schwartzkopff, Munch. Med. Wschr.,121, 529–533 (1979).Google Scholar
  79. 79.
    W. Schwartzkopff, Med. Welt. (Stuttg.),38, 1151–1156 (1987).Google Scholar
  80. 80.
    H. C. Seftel, S. G. Baker, M. P. Sandier, et al., Br. Med. J.,281, 633–636 (1980).Google Scholar
  81. 81.
    R. D. Sharma, Atherosclerosis,37, 463–468 (1980).Google Scholar
  82. 82.
    T. Shimamoto, F. Numano, and T. Fujita, Am. Heart J.,71, 216–222 (1966).Google Scholar
  83. 83.
    T. Shimamoto and T. Sunaga, Atherogenesis, T. Shimamoto et al. (eds.), Amsterdam (1973), pp. 3–31.Google Scholar
  84. 84.
    H. Shimokawa, H. Tomoike, S. Nabeyama, et al., Science,221, 560–562 (1983).Google Scholar
  85. 85.
    I. Sircar, M. Hoefle, and R. E. Maxwell, J. Med. Chem.,26, 1020–1027 (1983).Google Scholar
  86. 86.
    C. R. Sirtori, G. Gianfranceschi, M. Sirtori, et al., Atherosclerosis,38, 267–271 (1981).Google Scholar
  87. 87.
    A. Subissi, P. Schantarelli, M. Briagi, and G. Sardelli, Atherosclerosis,36, 135–148 (1980).Google Scholar
  88. 88.
    J. M. Thorp and W. S. Waring, Nature,194, 948–949 (1962).Google Scholar
  89. 89.
    J. A. Tobert, G. D. Bell, J. Birtwell, et al., J. Clin. Invest.,69, 913–919 (1982).Google Scholar
  90. 90.
    G. Troendle, J. Gueriguian, S. Sobel, and M. Johnson, Lancet,1, 1179 (1982).Google Scholar
  91. 91.
    R. B. Wallace, G. B. Hunninghake, S. Reilands, et al., Circulation,62, Suppl. 4, 77–82 (1980).Google Scholar
  92. 92.
    D. B. Weinstein and J. G. Heiger, Am. J. Cardiol.,59, 163B-172B (1987).Google Scholar
  93. 93.
    A. L. Willis, D. L. Smith, and C. Vigo, Prog. Lipid Res.,25, 645–666 (1986).Google Scholar
  94. 94.
    A. Yamamoto, H. Sudo, and A. Sudo, Atherosclerosis,35, 259–266 (1980).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • G. Ya. Shvarts
    • 1
  1. 1.S. Ordzhonikidze All-Union Research Institute for Pharmaceutical ChemistryMoscow

Personalised recommendations